Traeger-Synodinos J, Kanavakis E, Kalogerakou M, Soulpi K, Missiou-Tsangaraki S, Kattamis C
First Department of Pediatrics, Athens University, Greece.
Hum Genet. 1994 Nov;94(5):573-5. doi: 10.1007/BF00211031.
The presence of nine mutations in the phenylalanine hydroxylase (PAH) gene, previously described in phenylketonuria (PKU) patients of other Mediterranean and European populations, was assessed in 47 Greek PKU and 3 hyperphenylalaninaemia (HPA) patients. Of the nine mutations investigated, only five were detected, characterizing 31% of the PKU alleles in our patients.
在47名希腊苯丙酮尿症(PKU)患者和3名高苯丙氨酸血症(HPA)患者中,评估了先前在其他地中海和欧洲人群的PKU患者中描述的苯丙氨酸羟化酶(PAH)基因中的9种突变。在所研究的9种突变中,仅检测到5种,其在我们患者的PKU等位基因中占31%。